Tobias Else

11.1k total citations · 2 hit papers
135 papers, 4.9k citations indexed

About

Tobias Else is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Tobias Else has authored 135 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Surgery, 64 papers in Endocrinology, Diabetes and Metabolism and 54 papers in Cancer Research. Recurrent topics in Tobias Else's work include Adrenal and Paraganglionic Tumors (63 papers), Cancer, Hypoxia, and Metabolism (51 papers) and Hormonal Regulation and Hypertension (41 papers). Tobias Else is often cited by papers focused on Adrenal and Paraganglionic Tumors (63 papers), Cancer, Hypoxia, and Metabolism (51 papers) and Hormonal Regulation and Hypertension (41 papers). Tobias Else collaborates with scholars based in United States, Denmark and France. Tobias Else's co-authors include Gary D. Hammer, Thomas J. Giordano, Barbra S. Miller, Shruti Jolly, William E. Rainey, Victoria M. Raymond, Aaron Sabolch, Alex C. Kim, Elaine M. Caoili and Kazutaka Nanba and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Tobias Else

123 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adrenocortical Carcinoma

2013 575 citations Tobias Else, Victoria M. Raymond et al. profile →
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

2018 562 citations Olaf M. Dekkers, Tobias Else et al. European Journal of Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tobias Else United States	35	3.2k	2.5k	2.2k	1.1k	726	135	4.9k
Frédérique Tissier France	38	3.6k 1.1×	2.6k 1.0×	2.7k 1.2×	1.0k 1.0×	658 0.9×	96	5.1k
Jan Zedenius Sweden	39	1.5k 0.5×	3.0k 1.2×	645 0.3×	1.5k 1.5×	147 0.2×	146	5.2k
Maria Cláudia Nogueira Zerbini Brazil	23	1.3k 0.4×	665 0.3×	855 0.4×	438 0.4×	307 0.4×	126	2.1k
Barbara Pasini Italy	34	1.8k 0.6×	1.3k 0.5×	900 0.4×	2.0k 1.9×	111 0.2×	92	5.4k
Béatrice Parfait France	30	616 0.2×	490 0.2×	629 0.3×	1.5k 1.4×	115 0.2×	83	3.3k
Joy D. Cogan United States	37	561 0.2×	1.1k 0.4×	361 0.2×	1.4k 1.3×	360 0.5×	84	5.0k
Terry C. Lairmore United States	32	1.7k 0.5×	1.7k 0.7×	340 0.2×	620 0.6×	35 0.0×	81	4.0k
Valérie Barbier Australia	27	256 0.1×	319 0.1×	362 0.2×	1.2k 1.1×	490 0.7×	63	3.4k
Eric Jullian France	17	691 0.2×	304 0.1×	459 0.2×	395 0.4×	138 0.2×	23	1.6k
Masayuki Koizumi Japan	25	849 0.3×	202 0.1×	406 0.2×	1.6k 1.5×	76 0.1×	53	3.0k

Countries citing papers authored by Tobias Else

Since Specialization

Citations

This map shows the geographic impact of Tobias Else's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Else with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Else more than expected).

Fields of papers citing papers by Tobias Else

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Else. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Else. The network helps show where Tobias Else may publish in the future.

Co-authorship network of co-authors of Tobias Else

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Else. A scholar is included among the top collaborators of Tobias Else based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Else. Tobias Else is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Srinivasan, Ramaprasad, Othon Iliopoulos, Kathryn E. Beckermann, et al.. (2025). Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study. The Lancet Oncology. 26(5). 571–582. 2 indexed citations

Li, Xiaochen, Erika Koeppe, Phillip L. Palmbos, et al.. (2025). Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial Carcinoma. Clinical Genitourinary Cancer. 23(6). 102451–102451.

Else, Tobias, Ka Kit Wong, Kirk A. Frey, et al.. (2024). 3-[18F]Fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) PET—A Novel Imaging Modality for Paraganglioma. Journal of the Endocrine Society. 8(6). bvae049–bvae049. 5 indexed citations

Else, Tobias, Eric Jonasch, Othon Iliopoulos, et al.. (2024). Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study. Clinical Cancer Research. 30(9). 1750–1757. 11 indexed citations

Rivero, Jaydira Del, Tobias Else, Julie Hallanger‐Johnson, et al.. (2024). A review of mitotane in the management of adrenocortical cancer. The Oncologist. 29(9). 747–760. 5 indexed citations

Vaishampayan, Ulka N., et al.. (2024). Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma. Cancers. 16(3). 601–601. 12 indexed citations

Iliopoulos, Othon, Vivek Narayan, Kathryn E. Beckermann, et al.. (2024). Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study. The Lancet Oncology. 25(10). 1325–1336. 16 indexed citations

Beuschlein, Felix, Tobias Else, Irina Bancos, et al.. (2024). European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. The Journal of Clinical Endocrinology & Metabolism. 109(7). 1657–1683. 27 indexed citations

Beuschlein, Felix, Tobias Else, Irina Bancos, et al.. (2024). European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. European Journal of Endocrinology. 190(5). G25–G51. 29 indexed citations

10.

Narayan, Vivek, Othon Iliopoulos, Benjamin L. Maughan, et al.. (2023). SYST-18 BELZUTIFAN TREATMENT FOR PATIENTS WITH VON HIPPEL-LINDAU DISEASE–ASSOCIATED CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS ENROLLED IN THE PHASE 2 LITESPARK-004 STUDY. Neuro-Oncology Advances. 5(Supplement_3). iii31–iii31. 1 indexed citations

11.

Clay, Michael R., Emília M. Pinto, Lauren Fishbein, Tobias Else, & Katja Kiseljak‐Vassiliades. (2021). Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 107(4). 1159–1169. 9 indexed citations

12.

Wiley, Henry E., Hanna R. Coleman, Eric Jonasch, et al.. (2021). Oral HIF-2α inhibitor belzutifan for ocular von Hippel-Lindau (VHL) disease. Investigative Ophthalmology & Visual Science. 62(8). 32–32. 4 indexed citations

13.

Nanba, Kazutaka, Adina F. Turcu, Lili Zhao, et al.. (2021). Intratumoral steroid profiling of adrenal cortisol-producing adenomas by liquid chromatography- mass spectrometry. The Journal of Steroid Biochemistry and Molecular Biology. 212. 105924–105924. 5 indexed citations

14.

Greenberg, Samantha, Michelle F. Jacobs, Heather Wachtel, et al.. (2020). Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma–pheochromocytoma syndrome. Genetics in Medicine. 22(12). 2101–2107. 18 indexed citations

15.

Mohan, Dipika R., Antônio Marcondes Lerário, Tobias Else, et al.. (2019). Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma. Clinical Cancer Research. 25(11). 3276–3288. 46 indexed citations

16.

Nanba, Kazutaka, Anand Vaidya, Gordon H. Williams, et al.. (2017). Age-Related Autonomous Aldosteronism. Circulation. 136(4). 347–355. 126 indexed citations

17.

Wilson, Tremika L.S., Namita G. Hattangady, Antônio Marcondes Lerário, et al.. (2017). A new POT1 germline mutation—expanding the spectrum of POT1-associated cancers. Familial Cancer. 16(4). 561–566. 31 indexed citations

18.

Raymond, Victoria M., Jessica N. Everett, Larissa V. Furtado, et al.. (2013). Adrenocortical Carcinoma Is a Lynch Syndrome–Associated Cancer. Journal of Clinical Oncology. 31(24). 3012–3018. 134 indexed citations

19.

Giordano, Thomas J., Rork Kuick, Tobias Else, et al.. (2009). Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling. Clinical Cancer Research. 15(2). 668–676. 292 indexed citations

20.

Else, Tobias & Gary D. Hammer. (2005). Genetic analysis of adrenal absence: agenesis and aplasia. Trends in Endocrinology and Metabolism. 16(10). 458–468. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact